RHEUMA DERMA CROSS TALK Overview and Management of Psoriasis and Psoriatic Arthritis

Speciality: All Speciality


Speaker:

Dr Ashwini Kamath | Consultant Rheumatologist Yenepoya Speciality Hospital, Kodialbail, Mangalore

Dr Ramesh Bhat M | Consultant & Professor Department of Dermatology Father muller hospital, Kankanady, Mangalore

Description:

A warm welcome to all the medical professionals in this interesting session on Exploring psoriasis and psoriatic arthritis management through Rheuma-Derma crosstalk.

The Rheuma-Derma Crosstalk delves into the interconnectedness of psoriasis and psoriatic arthritis, presenting a comprehensive overview and management strategies. Psoriasis, a chronic autoimmune skin disease, often coexists with psoriatic arthritis, a related inflammatory joint condition. Understanding this association is crucial for effective management, as treatments targeting one condition can impact the other. Management approaches encompass a multidisciplinary approach, involving dermatologists and rheumatologists collaborating closely.

Therapeutic interventions range from topical treatments and phototherapy for skin manifestations to disease-modifying anti-rheumatic drugs (DMARDs) and biologic agents for joint symptoms. Additionally, lifestyle modifications and patient education play pivotal roles in optimizing outcomes.

By addressing both dermatologic and rheumatologic aspects, the Rheuma-Derma Crosstalk aims to enhance patient care and improve quality of life for individuals with psoriasis and psoriatic arthritis.

Therefore, get an overall knowledge on Exploring psoriasis and psoriatic arthritis management through Rheuma-Derma crosstalk. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.

 

 

 

 

 

 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

4.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

5.

Virtual Reality Travel Reduces Cancer Pain.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot